
- /
- Supported exchanges
- / MU
- / ZOE.MU
Zoetis Inc (ZOE MU) stock market data APIs
Zoetis Inc Financial Data Overview
There is no Profile data available for ZOE.MU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Zoetis Inc data using free add-ons & libraries
Get Zoetis Inc Fundamental Data
Zoetis Inc Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Zoetis Inc News

Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors
In the latest close session, Zoetis (ZTS) was down 1.32% at $146.25. The stock fell short of the S&P 500, which registered a gain of 0.47% for the day. On the other hand, the Dow registered a gain of ...


Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain
Zoetis ZTS announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) has issued a positive opinion for its investigational monoclonal antibody (mAb) therapy, ...

Zoetis (ZTS) Gains Positive Opinion For Portela Therapy In EU For Cat OA Pain Relief
Zoetis recently received a positive opinion from the European Medicines Agency's CVMP for its pain relief therapy, Portela, expected to enhance its product line for feline osteoarthritis. The company ...

Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
PARSIPPANY, N.J., September 12, 2025--(BUSINESS WIRE)--Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) has adopted a posi...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.